BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6129361)

  • 21. The use of drugs for behavior modification as it relates to the practice of optometry--Part II.
    Koetting JF
    J Am Optom Assoc; 1977 Feb; 48(2):213-22. PubMed ID: 16048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mutagenic activity of psychotropic and anticonvulsant drugs].
    Zolotareva GN; Lavretskaia EF; Oblapenko NG; Suraĭkina TI; Fonshteĭn LM
    Tsitol Genet; 1976; 10(4):267-76. PubMed ID: 10656
    [No Abstract]   [Full Text] [Related]  

  • 23. [Synthesis and evaluation of central nervous system activity of new triaza-spirodecanediones].
    Coudert P; Rubat C; Couquelet JM; Bastide J; Bastide P
    Pharm Acta Helv; 1991; 66(5-6):155-9. PubMed ID: 1686098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Poisonings with psychotropic drug mixtures: analysis using the thin-layer chromatography method].
    Kiliuviene G; Vainauskas P; Zevzikovas A; Dirse V
    Medicina (Kaunas); 2002; 38(5):550-2. PubMed ID: 12474689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Psychodrugs in anesthesiology].
    Frosali L; Salvini L
    Acta Anaesthesiol; 1967; 18(5):649-745. PubMed ID: 4890106
    [No Abstract]   [Full Text] [Related]  

  • 26. Medicinal plants in tropical West Africa. II. Plants acting on the nervous system.
    Oliver-Bever B
    J Ethnopharmacol; 1983 Jan; 7(1):1-93. PubMed ID: 6132025
    [No Abstract]   [Full Text] [Related]  

  • 27. [Parameters for adsorption chromatography. 6. Adsorption parameters within a group of CNS-active substances and their importance for structure-activity relationships].
    Perĭna Z; Sarsúnová M; Zemanová E; Protiva M
    Pharmazie; 1989 Feb; 44(2):125-8. PubMed ID: 2748694
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemiluminescence and electrochemiluminescence detection of controlled drugs.
    Adcock JL; Barrow CJ; Barnett NW; Conlan XA; Hogan CF; Francis PS
    Drug Test Anal; 2011 Mar; 3(3):145-60. PubMed ID: 21154734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroendocrine markers of CNS drug effects.
    Johnstone EC; Ferrier IN
    Br J Clin Pharmacol; 1980 Jul; 10(1):5-21. PubMed ID: 6104974
    [No Abstract]   [Full Text] [Related]  

  • 30. Minimal brain dysfunction.
    Piepho RW; Gourley DR; Hill JW
    J Am Pharm Assoc; 1977 Aug; 17(8):500-4. PubMed ID: 19519
    [No Abstract]   [Full Text] [Related]  

  • 31. [Suicide attempt using hypnotics, psychotropic drugs and analgetics].
    Grüneberg F; Ibe K
    Internist (Berl); 1972 May; 13(5):209-15. PubMed ID: 4403073
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacology of the central nervous system.
    Nelson SR; Walaszek EJ
    Prog Neurol Psychiatry; 1971; 26():123-49. PubMed ID: 4151158
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmaceutical chemistry of sedato-hypnotics and anxiolytics].
    Takácsné NK; Szász G
    Acta Pharm Hung; 2004; 74(4):237-51. PubMed ID: 16316052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Congenital malformations with psychopharmacologic agents.
    Ananth J
    Compr Psychiatry; 1975; 16(5):437-45. PubMed ID: 240643
    [No Abstract]   [Full Text] [Related]  

  • 35. News in chemistry of psychotropic drugs in the year 1969.
    Protiva M
    Act Nerv Super (Praha); 1970; 12(3):193-214. PubMed ID: 4394019
    [No Abstract]   [Full Text] [Related]  

  • 36. Uropharmacology: X. Central nervous system stimulants and depressants.
    Bissada NK; Finkbeiner AE; Welch LT
    Urology; 1979 Apr; 13(4):464-73. PubMed ID: 34918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of drugs and their metabolites by high-performance liquid chromatography. A review.
    Wheals BB; Jane I
    Analyst; 1977 Sep; 102(1218):625-44. PubMed ID: 333985
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of high pressure liquid chromatography for the separation of drugs of abuse.
    Chan ML; Whetsell C; McChesney JD
    J Chromatogr Sci; 1974 Sep; 12(9):512-6. PubMed ID: 4472421
    [No Abstract]   [Full Text] [Related]  

  • 39. Rebound phenomena: results of a 10 years' (1970--1980) literature review.
    Lupolover R; Dazzi H; Ward J
    Int Pharmacopsychiatry; 1982; 17(4):194-237. PubMed ID: 6136487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guide to urine testing in drug abuse prevention and multi-modality treatment programs.
    Kaistha KK
    J Chromatogr; 1977 Aug; 141(2):145-96. PubMed ID: 19493
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.